Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000812295-02-000113
Filing Date
2002-02-14
Accepted
2002-02-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 osipharm.txt SC 13G/A 11447
  Complete submission text file 0000812295-02-000113.txt   13493
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 02542941
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 100 FILLMORE STREET SUITE 300 DENVER CO 80206-4923
Business Address 100 FILLMORE STREET SUITE 300 DENVER CO 80206-4923 3033333863
JANUS CAPITAL CORP (Filed by) CIK: 0000812295 (see all company filings)

State of Incorp.: CO | Fiscal Year End: 1231
SIC: 0000